CanGaroo
Commercial- Indications
- Device protection for implantable electronic devices
Company intelligence / Profile preview
Berkeley Biologics provides a portfolio of allograft and cellular matrix products for orthopedic and reconstructive bone grafting procedures. Their products are used clinically across spine, sports medicine, trauma, dental, and wound care indications. The company emphasizes gentle processing methods to preserve tissue properties and ensure safety. No clinical trial results are published as these are regulated human tissue/biologic implants.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berkeley Biologics.